EAPC abstract notification emails out today kids.

I don’t go on Twitter/ X much now but for those who still follow me please consider supporting Melanie in her charity fundraiser. It is a great cause and your support would be really appreciated. Please restore my faith in this platform. socialsync.app/fundraiser/cr…

Incredibly interesting, mixed methods study on antithrombotic therapy (ATT) during advanced cancer care. Experienced clinicians we're more likely to deprescribe ATT & patient choice was a key decision maker in that action #SERENITY #Antithrombotic #anticoagulation #ISTH2025

Hot off the press! COBBRA trial showed that apixaban is associated with >50% reduced risk of clinically-relevant bleeding symptoms for acute VTE treatment. This can be practice changing! @LanaCastellucci @RodgerMarc @canvector

Is this the end of rivaroxaban for acute VTE? @LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025

These are the 'seats' for wheelchair users for a 3 hour train journey to Manchester. No seat to transfer into. No table for a cup of coffee or laptop to work. New trains should be better than this @tfwrail @Tanni_GT

💜 How we talk about blood clots matters. 💜 🏥 The VTE Communication Guide was created to help clinicians navigate the complex conversations that follow a venous thromboembolism (VTE) diagnosis from risk and treatment to emotions and uncertainty. ❤️ This project brings together insights from global experts across clinicians, mental health and communication experts, and patients' lived experiences to create a free, practical tool for any clinician who wants to improve how they connect with patients during a vulnerable time. 📣 The guide includes conversation tips, communication strategies, patient-friendly language, and real-world examples across different stages of care. 🔗 Learn more about the project and explore the full guide here: lnkd.in/g-fieFf9 and the companion publication in Lancet Haematology here: lnkd.in/gkVEbjz8. 💜 A huge thank you to the incredible contributors and reviewers who helped bring this guide to life. Your time, expertise, and dedication to patient-centered care are what make this resource so powerful.Let’s keep pushing for clearer, kinder, and more collaborative conversations in VTE care. Shout out to: Aviva Schwartz, @SCWollerMD , Grégoire LE GAL, @Erik_Klok_MD , Samarth Mishra, Ana Thereza Rocha, @DieuwkeLuijten , Jackeline Hernandez, Jeffrey Habert, @klinelab , @JulieEBayley , @kerstindewit , @Liesbeth_vVliet , Nancy Mburu, @IsthPresident , @psadeghipour , @RosaTalerico , @SimonNoble,Toby Richards.

Someone more famous than you!

Was great to catch up with the @MarieCurieEOLC Team at #EAPC2025 over the last few days. Safe journey home and hope to see you all soon 😊@sabinebest @A_Finucane @MCPCRCCardiff @SysReviews

#EAPC2025 Check out Poster 40 all about teaching children about grief. @stephsivell @EmilyHarrop10 @SimonNoble @DPMRes @CUmedicengage @cardiffuni

#EAPC2025 👀@SysReviews presents a poster about a narrative review on the barriers to the delivery of specialist palliative care for patients with non-malignant liver disease. @MCPCRCCardiff @MarieCurieEOLC @SimonNoble @DPMRes @CUmedicengage @cardiffuni

#EAPC2025 📢 see Poster 40 about grief education in the school curriculum as part of the Marie Curie PADDUK Survey 2023 on attitudes to death, dying and bereavement in the UK. @MCPCRCCardiff @MarieCurieEOLC @EmilyHarrop10 @SimonNoble @DPMRes @CUmedicengage @cardiffuni

Checkout our poster no 735, on the barriers to the delivery of specialist palliative care for patients with advanced non-malignant liver disease. @MCPCRCCardiff @MarieCurieEOLC @SimonNoble @DPMRes @CUmedicengage @cardiffuni @MCPCRCCardiff

High level academic meeting with ⁦@alex_tonks⁩. In 30 minutes we managed to sort out the school finances, curriculum and REF. #leadership #collaboration #fibs

Fantastic day at the ⁦@ThrombosisUK⁩ awards. Bumped into an old friend whilst waiting for my train home.

Did you (or someone you know) care for a terminally ill family member who died when you were aged 25 or under? If so please consider taking part in one of our online focus groups to help us improve support for young carers. Pls contact me on harrope@cardiff.ac.uk. Many thanks!

Best. Present. Ever.

The Death Literacy Research Network led by Dr Michelle Edwards are having their first webinar on the 23rd May to explore ways of understanding death literacy in Wales. Register with the link below: events.teams.microsoft.com/e…

Study API-CAT: Low-dose apixaban proved noninferior to full-dose for extended #VTE prevention in active cancer—with significantly less bleeding. Practice-changing. bit.ly/3E4UxFk #ACC25 #Oncology @isabellemahe1 @DSadlerMD @SimonNoble @NEJM